The move could help make the treatment available to more than half of the world’s population.

LONDON (AP) — Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill.

The move could help make the treatment available to more than half of the world’s population.

READ MORE: Protest Held Outside Allegheny County Executive Rich Fitzgerald's Home Hours Before COVID-19 Vaccination Deadline For Employees

In a statement on Tuesday, Pfizer said it would grant a license for the antiviral pill to the Medicines Patent Pool.

The agreement lets generic drug companies make the pill for use in 95 countries.

READ MORE: 5,000-6,000 Gallons Of Gas Spilled Into Washington County Stream

The deal excludes some large countries with manufacturing capacity.

But health officials say the fact that the deal was struck before Pfizer’s pill has been authorized anywhere could help end the pandemic more quickly.

MORE NEWS: Liquor Control Board Report Reveals Unflavored Vodka As Top-Selling Drink In Pennsylvania

(Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)